PetIQ acquisition of MYOS
We advised Bansk Group and its portfolio company PetIQ on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Cross Country Healthcare sale to Knox Lane
We are advising Cross Country Healthcare on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Cross Country Healthcare $615 million acquisition by Aya Healthcare
We are advising Cross Country Healthcare on the transaction
Bansk Group $1.5 billion going-private acquisition of PetIQ
We are advising Bansk Group on the transaction
Greenway Health $375 million refinancing
We advised the administrative agent, arrangers and bookrunners on the financing
Evolent Health $402.5 million convertible notes offering
The convertible notes are due 2029
DexCom $1.25 billion convertible notes offering and capped call transactions
The 0.375% convertible senior notes are due 2028
Priveterra Acquisition initial business combination with AEON Biopharma
We are advising Priveterra on the transaction
IVERIC bio $324.7 million stock offering
The shares are listed on the Nasdaq Global Select Market